.svg.png)
The U.S. market for cell and gene therapies is estimated to reach $25.58 billion by 2028, with the FDA set to approve 20 cell and 31 gene therapies in 2024.
Posts By Author
Is AI the Answer to Healthcare Billing Problems?
Oxford weighs in on how AI solutions from Google Cloud can help relieve tensions around healthcare billing concerns.
FinTech is Disrupting Traditional Asset and Wealth Management
Discover the future of asset and wealth management with FinTech. Learn how it can optimize efficiency, accessibility, and personalization.
BI Platforms to Revolutionize the Way You Do Business
When choosing a BI platform, it’s important to consider scalability, ease of use, and integration with existing systems to make informed data-driven decisions.
Automating the Lab
Laboratories can use robotics and technology to streamline and enhance various scientific processes, reducing human intervention and increasing efficiency.